UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2969) 2969
Book Chapter (31) 31
Publication (5) 5
Dissertation (3) 3
Poster (3) 3
Conference Proceeding (2) 2
Magazine Article (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
nivolumab (2424) 2424
science & technology (2106) 2106
life sciences & biomedicine (2089) 2089
humans (1579) 1579
oncology (1330) 1330
immunotherapy (1140) 1140
male (768) 768
melanoma (706) 706
pembrolizumab (704) 704
female (672) 672
ipilimumab (641) 641
aged (618) 618
middle aged (617) 617
metastasis (564) 564
lung cancer (492) 492
patients (488) 488
nivolumab - therapeutic use (467) 467
cancer (465) 465
chemotherapy (435) 435
antibodies, monoclonal - therapeutic use (414) 414
antineoplastic agents, immunological - therapeutic use (407) 407
lung neoplasms - drug therapy (406) 406
care and treatment (402) 402
programmed cell death 1 receptor - antagonists & inhibitors (386) 386
cancer therapies (384) 384
treatment outcome (354) 354
nivolumab - adverse effects (350) 350
antineoplastic agents, immunological - adverse effects (338) 338
adult (330) 330
case report (324) 324
antineoplastic agents - therapeutic use (319) 319
immunology (308) 308
melanoma - drug therapy (308) 308
pd-1 (303) 303
tumors (292) 292
carcinoma, non-small-cell lung - drug therapy (288) 288
immune checkpoint (288) 288
antibodies, monoclonal - adverse effects (274) 274
apoptosis (273) 273
aged, 80 and over (245) 245
clinical trials (241) 241
drug therapy (235) 235
neoplasms. tumors. oncology. including cancer and carcinogens (221) 221
immunotherapy - methods (216) 216
lymphocytes (216) 216
metastases (216) 216
lung cancer, non-small cell (208) 208
antibodies, monoclonal, humanized - therapeutic use (203) 203
immune checkpoint inhibitors (202) 202
antineoplastic agents - adverse effects (195) 195
research (190) 190
antineoplastic combined chemotherapy protocols - therapeutic use (186) 186
nivolumab - administration & dosage (186) 186
prognosis (186) 186
dermatology (184) 184
lung neoplasms - pathology (183) 183
programmed cell death 1 receptor - immunology (181) 181
pd-l1 (180) 180
medical prognosis (179) 179
pd-1 protein (176) 176
non-small cell lung cancer (175) 175
analysis (174) 174
immune checkpoint inhibitor (167) 167
atezolizumab (166) 166
retrospective studies (166) 166
cell death (164) 164
medicine & public health (162) 162
biomarkers (159) 159
mutation (159) 159
skin neoplasms - drug therapy (156) 156
melanoma - pathology (155) 155
cytotoxicity (152) 152
pharmacology & pharmacy (150) 150
general & internal medicine (143) 143
respiratory system (143) 143
medicine, general & internal (138) 138
b7-h1 antigen - antagonists & inhibitors (137) 137
ligands (136) 136
non-small cell lung carcinoma (135) 135
antibodies, monoclonal - administration & dosage (134) 134
antigens (133) 133
hematology (130) 130
medical research (130) 130
antineoplastic agents, immunological - administration & dosage (129) 129
checkpoint inhibitors (129) 129
monoclonal antibodies (129) 129
development and progression (128) 128
carcinoma, non-small-cell lung - pathology (126) 126
carcinoma, renal cell - drug therapy (124) 124
health aspects (124) 124
neoplasm staging (124) 124
immune system (122) 122
review (120) 120
immune-related adverse events (119) 119
survival (118) 118
usage (118) 118
survival analysis (113) 113
lymphocytes t (112) 112
antibodies (111) 111
ipilimumab - therapeutic use (111) 111
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2895) 2895
Japanese (47) 47
French (29) 29
Russian (26) 26
Korean (25) 25
Chinese (14) 14
German (14) 14
Czech (6) 6
Italian (5) 5
Spanish (5) 5
Norwegian (2) 2
Polish (2) 2
Croatian (1) 1
Danish (1) 1
Dutch (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 11/2019, Volume 381, Issue 21, pp. 2020 - 2031
Patients with advanced non–small-cell lung cancer with a PD-L1 expression level of 1% or more of tumor cells were randomly assigned to receive nivolumab plus... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antineoplastic Agents, Immunological - administration & dosage | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Lung Neoplasms - metabolism | Middle Aged | Carcinoma, Non-Small-Cell Lung - metabolism | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Ipilimumab - adverse effects | Nivolumab - adverse effects | Carcinoma, Non-Small-Cell Lung - mortality | Antineoplastic Agents, Immunological - adverse effects | B7-H1 Antigen - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged, 80 and over | Adult | Female | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Ipilimumab - administration & dosage | Nivolumab - administration & dosage | Lung cancer, Non-small cell | Drug therapy | Patient outcomes | Ipilimumab | Testing | Small cell lung carcinoma | Lung cancer | Non-small cell lung carcinoma | Oncology | Cancer therapies | Chemotherapy | Immunotherapy | PD-L1 protein | Biomarkers | Clinical medicine | Mutation | Drug dosages | Apoptosis | Tumors | Index Medicus | Abridged Index Medicus | B7-H1 Antigen | Carcinoma, Non-Small-Cell Lung | Antineoplastic Combined Chemotherapy Protocols | Cellular Biology | Lung Neoplasms | Life Sciences | Antineoplastic Agents, Immunological | Nivolumab
Journal Article
Journal Article
Oral oncology, ISSN 1368-8375, 06/2018, Volume 81, pp. 45 - 51
Journal Article
The New England journal of medicine, ISSN 1533-4406, 10/2017, Volume 377, Issue 14, pp. 1345 - 1356
Journal Article
The lancet oncology, ISSN 1470-2045, 11/2018, Volume 19, Issue 11, pp. 1480 - 1492
Journal Article
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 10/2019, Volume 381, Issue 16, pp. 1535 - 1546
Journal Article